Treace Medical - TMCI Short-Term Debt to Capital

Treace Medical Concepts (TMCI) generates revenue through the sale of proprietary Lapiplasty systems, assisting orthopedic surgeons in effectively correcting foot deformities. Financial stability relies on the sale of titanium plates, which provide a steady income stream via a consumables model. The current metric stands at 0.00. The development of new minimally invasive instruments and medical training support technological growth. This chart illustrates the market value of the debt-to-equity ratio.

This metric determines the proportion of short-term liabilities relative to equity, measuring Treace Medical Concepts (TMCI) dependence on operational debt financing. This ratio is critical for assessing liquidity and the portfolio's resilience to sudden market shocks. Analyzing the history of short-term debt to equity, we see a current value of 0.00. The stability of this indicator is maintained through rhythmic logistics and the diversification of orthopedic component suppliers.